🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, asserting the firms concealed alleged dangers that the medication presented to children's cognitive development.

This legal action comes a month after President Donald Trump publicized an unverified association between consuming Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is suing J&J, which once produced the medication, the only pain reliever suggested for pregnant women, and the current manufacturer, which currently produces it.

In a statement, he claimed they "misled consumers by gaining financially from discomfort and marketing drugs without regard for the dangers."

The manufacturer says there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, deliberately risking countless individuals to line their pockets," the attorney general, a Republican, said.

Kenvue commented that it was "deeply concerned by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the health of American women and children."

On its official site, Kenvue also stated it had "consistently assessed the applicable studies and there is lacking reliable evidence that demonstrates a proven link between taking acetaminophen and autism."

Associations speaking for physicians and medical practitioners concur.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the primary component in acetaminophen - is one of the few options for expectant mothers to manage discomfort and elevated temperature, which can present major wellness concerns if not addressed.

"In more than two decades of studies on the consumption of acetaminophen in gestation, zero credible investigations has successfully concluded that the usage of acetaminophen in any period of pregnancy leads to neurological conditions in children," the association commented.

This legal action mentions current declarations from the former administration in claiming the medication is allegedly unsafe.

In recent weeks, the former president generated worry from medical authorities when he advised pregnant women to "struggle intensely" not to use Tylenol when sick.

Federal regulators then published an announcement that physicians should contemplate reducing the consumption of acetaminophen, while also stating that "a causal relationship" between the drug and autism in minors has not been established.

Health Secretary RFK Jr, who oversees the FDA, had vowed in spring to undertake "comprehensive study program" that would determine the cause of autism spectrum disorder in a limited time.

But specialists advised that finding a single cause of autism - considered by experts to be the outcome of a intricate combination of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a type of enduring cognitive variation and condition that influences how persons perceive and engage with the surroundings, and is recognized using physician assessments.

In his legal document, Paxton - a Trump ally who is running for federal office - asserts Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around acetaminophen and autism.

The case aims to force the corporations "destroy any promotional materials" that claims Tylenol is reliable for women during pregnancy.

This legal action parallels the concerns of a assembly of parents of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of Tylenol in 2022.

A federal judge rejected the legal action, stating studies from the family's specialists was lacking definitive proof.